Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tykundegex]

Q about risk for the board... at this point the company seems all but guaranteed to file for, and receive approval for, an NDA for KIT-302. Furthermore, all signs point to it achieving significant penetration, once on the market. From my perspective, the little risk that exists in an investment in KTOV at this point is if they partner (vs. sell it) and only achieve very modest sales. But even with modest sales, the current MC is a farce, right?

Has anyone followed another biotech that has achieved all the KIT-302 milestones, and yet NOT gone on to make a commercial success out of it?

Only things I can think of might be:
1. last minute safety concerns -- virtually impossible as both compounds are FDA approved
2. manufacturing issues that cause a major delay -- improbable with their Israeli partner ?

Somebody please wake me... I don't get how I was able to take a position in Kitov at these prices given how advanced they are...